Eduardo Díaz‐Rubio
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 1%
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Co-authors
- Arié FigerJim CassidyLeonard B. SaltzWerner ScheithauerFernando RiveraStephen ClarkeSheryl KoskiJavier Sastre
- Topics
- Colorectal Cancer Treatments and Studies (146 papers)Cancer Treatment and Pharmacology (88 papers)Genetic factors in colorectal cancer (65 papers)
- Cited by
- OncologyHepatologyCancer Research
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Eduardo Díaz‐Rubio
340 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 8.7k
- Pulmonary and Respiratory Medicine 3.5k
- Surgery 2.4k
- Molecular Biology 2.0k
- Cancer Research 2.0k
Countries citing papers authored by Eduardo Díaz‐Rubio
This map shows the geographic impact of Eduardo Díaz‐Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Díaz‐Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Díaz‐Rubio more than expected).
Fields of papers citing papers by Eduardo Díaz‐Rubio
This network shows the impact of papers produced by Eduardo Díaz‐Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Díaz‐Rubio. The network helps show where Eduardo Díaz‐Rubio may publish in the future.
Co-authorship network of co-authors of Eduardo Díaz‐Rubio
This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Díaz‐Rubio. A scholar is included among the top collaborators of Eduardo Díaz‐Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Díaz‐Rubio. Eduardo Díaz‐Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 30 | |
| 7 | 22 | |
| 8 | 28 | |
| 9 | 36 | |
| 10 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Studybreakdown → | 2275 |
| 11 | 50 | |
| 12 | La investigación traslacional en oncología clínica: retos y oportunidades | 1 |
| 13 | 13 | |
| 14 | Cáncer de pulmón | 20 |
| 15 | 7 | |
| 16 | Pharmacoeconomic analysis of Capecitabine in the adjuvant setting. Results from the X-ACT trial comparing capecitabine with 5-FU/LV in patients with Dukes' C colon cancer | 7 |
| 17 | 0 | |
| 18 | Manejo de los tumores germinales testiculares en estadio precoz | 1 |
| 19 | 3 | |
| 20 | 17 |
About Eduardo Díaz‐Rubio
Eduardo Díaz‐Rubio is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine, having authored 351 papers that have together received 12.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (146 papers), Cancer Treatment and Pharmacology (88 papers) and Genetic factors in colorectal cancer (65 papers). The work is most often cited by research in Oncology (8.7k citations), Hepatology (2.0k citations) and Cancer Research (2.0k citations). Eduardo Díaz‐Rubio has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Arié Figer, Jim Cassidy, Leonard B. Saltz, Werner Scheithauer, Fernando Rivera, Stephen Clarke, Sheryl Koski, Javier Sastre, Tsai‐Shen Yang and Mikhail Lichinitser. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.